The Influence of Myrj 59 on the Solubility, Toxicity and Activity of Amphotericin B (Q28322976)

https://api.crossref.org/works/10.1111/J.2042-7158.1991.TB06693.X

27 October 2022

1 reference

pharmaceutical science

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1991.TB06693.X

27 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1991.TB06693.X

27 October 2022

author name string

C. Tasset

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1680169

27 October 2022

V. Préat

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1680169

27 October 2022

M. Roland

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1680169

full work available at URL

27 October 2022

language of work or name

English

0 references

publication date

May 1991

0 references

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.2042-7158.1991.tb06693.x

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1991.TB06693.X

http://academic.oup.com/jpp/article-pdf/43/5/297/37241321/j.2042-7158.1991.tb06693.x.pdf

27 October 2022

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1991.TB06693.X

Journal of Pharmacy and Pharmacology

27 October 2022

published in

0 references

volume

43

0 references

issue

5

0 references

page(s)

297-302

0 references

cites work

Pharmacologic probing of amphotericin B-induced renal dysfunction in the neonatal rat

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1991.TB06693.X

Effects of the detergent sucrose monolaurate on binding of amphotericin B to sterols and its toxicity for cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1991.TB06693.X

In vitro antifungal activities of amphotericin B and liposome-encapsulated amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1991.TB06693.X

An emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1991.TB06693.X

In-vivo studies of amphotericin B liposomes derived from proliposomes: effect of formulation on toxicity and tissue disposition of the drug in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1991.TB06693.X

Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposome-intercalated amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1991.TB06693.X

Differences in the interaction of the polyene antibiotic amphotericin B with cholesterol- or ergosterol-containing phospholipid vesicles. A circular dichroism and permeability study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1991.TB06693.X

How do the polyene macrolide antibiotics affect the cellular membrane properties?

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1991.TB06693.X

Polyene antibiotic-sterol interactions in membranes of Acholeplasma laidlawii cells and lecithin liposomes. 3. Molecular structure of the polyene antibiotic-cholesterol complexes

27 October 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1991.TB06693.X

Toxicity of solubilized and colloidal amphotericin B formulations to human erythrocytes

27 October 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1991.TB06693.X

Application of differential spectra in the ultraviolet-visible region to study the formation of amphotericin B-sterol complexes

27 October 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1991.TB06693.X

Effect of attachment of anticandidal antibody to the surfaces of liposomes encapsulating amphotericin B in the treatment of murine candidiasis

27 October 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1991.TB06693.X

Permeability alterations and antihaemolysis induced by amphiphiles in human erythrocytes

27 October 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1991.TB06693.X

Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B

27 October 2022

18

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1991.TB06693.X

Antileishmanial activity of amphotericin and other antifungal agents entrapped in liposomes

27 October 2022

19

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1991.TB06693.X

Treatment of experimental invasive aspergillosis with novel amphotericin B/cholesterol-sulfate complexes.

27 October 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1991.TB06693.X

Equilibrium binding of amphotericin B and its methyl ester and borate complex to sterols

27 October 2022

22

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1991.TB06693.X

Structural studies on aqueous and hydroalcoholic solutions of a polyene antibiotic: amphotericin B

27 October 2022

23

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1991.TB06693.X

Amphotericin B in liposomes: a novel therapy for histoplasmosis

27 October 2022

26

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1991.TB06693.X

Reduced toxicity of liposome-associated amphotericin B injected intravitreally in rabbits

27 October 2022

27

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1991.TB06693.X

27 October 2022

Identifiers

release_sg5a6emou5fxxkbsokjpbgioiy

0 references

Fatcat ID

0 references